Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

被引:1453
作者
Aggarwal, S
Ghilardi, N
Xie, MH
de Sauvage, FJ
Gurney, AL
机构
[1] Genentech Inc, Dept Biol Mol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
关键词
D O I
10.1074/jbc.M207577200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-17 is a pro-inflammatory cytokine that is produced by activated T cells. Despite increasing evidence that high levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis, and multiple sclerosis, the regulation of its expression is not well characterized. We observe that IL-17 production is increased in response to the recently described cytokine IL-23. We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion. IL-23 also induced expression of the related cytokine IL-17F. IL-23 is a heterodimeric cytokine and shares a subunit, p40, with IL-12. In contrast to IL-23, IL-12 had only marginal effects on IL-17 production. These data suggest that during a secondary immune response, IL-23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles.
引用
收藏
页码:1910 / 1914
页数:5
相关论文
共 35 条
[1]  
Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
[2]   Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes [J].
Albanesi, C ;
Scarponi, CS ;
Cavani, A ;
Federici, M ;
Nasorri, F ;
Girolomoni, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (01) :81-87
[3]  
Antonysamy MA, 1999, J IMMUNOL, V162, P577
[4]  
ANTONYSAMY MA, 1999, TRANSPLANT P, V31, P1
[5]  
BUDD RC, 1987, J IMMUNOL, V138, P3120
[6]   Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17 [J].
Cai, XY ;
Gommoll, CP ;
Justice, L ;
Narula, SK ;
Fine, JS .
IMMUNOLOGY LETTERS, 1998, 62 (01) :51-58
[7]  
Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO
[8]  
2-E
[9]  
Chabaud M, 1998, J IMMUNOL, V161, P409
[10]  
CHUA AO, 1995, J IMMUNOL, V155, P4286